← Open Payments lookup

PAIGE REED: Open Payments

NPI 1417679168 · NEWTON, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,139 in 67 payments from 14 companies in 2025. Trend: 2023 $1,208 · 2024 $1,417 · 2025 $1,139

Food & beverage: $1,139
CompanyPaymentsAmount
Alkermes, Inc.12$204
ABBVIE INC.13$198
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$188
Otsuka America Pharmaceutical, Inc.9$167
Lundbeck LLC5$77
Vanda Pharmaceuticals Inc.3$71
Neurocrine BioSciences, Inc.4$64
Teva Pharmaceuticals USA, Inc.2$40
E.R. Squibb & Sons, L.L.C.2$30
MDD US Operations, LLC2$29

Products named: VRAYLAR, CAPLYTA, ARISTADA, REXULTI, FANAPT, INGREZZA, ABILIFY MAINTENA, AUSTEDO XR.

Industry payments across IA — which companies pay providers there.